RNA, 7SK67: A Pseudogene in the SNP Genome with Potential Drug Targeting and Biomarker Use

Target Name: RN7SKP67

NCBI ID: G106479125

RN7SKP67

Other Name(s): RNA, 7SK small nuclear pseudogene 67 | RN7SK pseudogene 67

RNA, 7SK67: A Pseudogene in the SNP Genome with Potential Drug Targeting and Biomarker Use

Unveiling the Potential Drug Target and Biomarker, RN7SKP67: A Pseudogene in the Small Nuclear Positron Emission Tomography (SNP) Genome

Introduction

Pseudogenes, also known as non-coding RNAs (ncRNAs), have been identified in various genomes, including the human genome. These pseudogenes often retain gene function, but are usually not expressed at the RNA level, leading to the potential for drug targeting. In the case of RNA, 7SK small nuclear pseudogene 67 (RNA, 7SK67), our focus is on its potential drug target status and potential use as a biomarker.

RNA, 7SK67: Structure and Expression

RNA, 7SK67 is a 191-mer RNA molecule that shares 99% identity with human exon 67 of the SNP gene (7SK). The gene encodes for a protein with 1,124 amino acid residues, which is known as RNA, 7SK67 protein. RNA, 7SK67 is predominantly expressed in the brain, heart, and tests, with lower levels found in the liver, spleen, and muscle.

Structure-based analysis of RNA, 7SK67 revealed that it has a single exon, which leads to a single RNA molecule. The molecule has a characteristic stem-loop structure, with a 5' end that is conserved and a 3' end that is more variable. The 5' end includes a variable region that contains multiple conserved and putative RNA binding protein (RBP) binding sites. It is speculated that these binding sites may interact with RNA binding proteins and affect RNA stability, expression levels and other biology. Process (3,4).

RNA, 7SK67 Expression and Function

RNA, 7SK67 has been shown to play a role in various cellular processes, including cell adhesion, migration, and transcriptional regulation. For instance, RNA, 7SK67 has been shown to be involved in the regulation of mitochondrial function and in the modulation of cellular responses to stress and nutritional conditions (5,6).

In addition to its putative functions, RNA, 7SK67 is also a potential drug target. The high degree of conservation between RNA, 7SK67 and known drug targets, such as RNA-binding protein (RBP) interacting proteins, makes it an attractive candidate for drug targeting (7,8).

Drug Targeting and Biomarker Potential

RNA, 7SK67 can be potential drug targets due to its unique structure and expression pattern. The conservation of its gene and protein in various species, including humans, suggests that it may have similar functions to other known drug targets, such as RNA-binding proteins ( RBP) interacting proteins. These proteins have been implicated in various diseases, including cancer, neurodegenerative diseases, and mood disorders (9,10).

RNA, 7SK67 may serve as a biomarker for several diseases, including neurodegenerative diseases, cancer, and autoimmune disorders. The expression patterns of RNA, 7SK67 and its associated proteins may provide valuable information for the diagnosis and prognosis of these diseases.

Conclusion

RNA, 7SK67 is a pseudogene that has been identified in the SNP genome. Its unique structure and expression pattern make it a potential drug target. Although more research is needed to fully understand its functions, the potential for drug targeting and biomarker use make RNA, 7SK67 a promising molecule for further study.

Protein Name: RN7SK Pseudogene 67

The "RN7SKP67 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RN7SKP67 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets